كنفرانس بين المللی مهندسی صنايع و سيستم ها

صفحه اصلی / دهمین كنفرانس بين المللی مهندسی صنايع و سيستم ها

Iran's pharmaceutical supply chain risk assessment considering process's priority, hazard and probabilities

نویسندگان :

Ferial Zarrabi¹ Mohammad Rasouli²

1- پردیس دانشگاه تهران 2- پردیس دانشگاه تهران

کلمات کلیدی :

Pharmaceutical supply chain،Simple additive weighting،BOCR Risk assessment،Iran pharmaceutical industry،Fuzzy method،(SAW) method

چکیده :

Over the years, the pharmaceutical distribution chain has encountered escalating competition and globalization, significantly impacting the progression and management of the chain. Various dangers have surfaced at different levels of the pharmaceutical distribution chain due to these worldwide dynamics. The global expansion of distribution chains has resulted in increased vulnerability to dangers and frequent interruptions at various stages. This manuscript recognizes and ranks crucial dangers in the pharmaceutical distribution chain using the Fuzzy-SAW (Simple Additive Weighting) approach. Goals: The pharmaceutical distribution chain plays a pivotal role in the healthcare structure by guaranteeing the delivery of medications, particularly in nations where local pharmaceutical businesses offer necessary medicines. Dangers affecting pharmaceutical enterprises can obstruct the delivery of medications and influence the effectiveness of the healthcare structure. This analysis aims to appraise dangers in the pharmaceutical sector in Iran, taking into account the precedence of procedures, dangers, and the likelihood of risks. Techniques: The analysis was carried out in four phases: (1) danger identification through literature examination, (2) danger identification in pharmaceutical enterprises through expert discussions, (3) danger evaluation via a survey and expert conversations using the fuzzy approach and a grading scale (RS), and (4) danger estimation using the Simple Additive Weighting approach. Findings: A total of 28 primary dangers were recognized in the pharmaceutical distribution chain from the viewpoint of pharmaceutical companies, classified into four categories (BOCR: Benefits, Opportunities, Costs, and Risks). The study stressed that most of the significant dangers were linked to these 15 key risks within 4 categories.